FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Apr. 21, 2014--
MEDNAX, Inc., (NYSE: MD) today announced the acquisition of
Fredericksburg Anesthesia Associates, Inc., a private practice physician
group based in Fredericksburg, Va. The practice will become part of
MEDNAX’s American Anesthesiology division and is the third
Virginia-based anesthesia practice to join the division.
Fredericksburg Anesthesia Associates employs 16 anesthesiologists who
provide anesthesia services as part of a care team model that includes
anesthetists at Mary Washington Hospital, Stafford Hospital and
Fredericksburg Ambulatory Surgery Center. Their services include general
surgery, orthopedic, cardiovascular, thoracic, neurosurgery (including
spine), pediatric, obstetric and gynecological, as well as acute pain
management. The practice’s founding physicians began providing
anesthesia services to Fredericksburg and surrounding communities in
1965 and the practice was incorporated in 1992.
“We chose to partner with American Anesthesiology to ensure that our
group can continue to focus on patient care and outcomes in an
increasingly competitive and complicated healthcare environment,” said
W. Scott Brosche, M.D., who will serve as medical director for the
practice. “The company’s proven integration process ensures that we will
have strong support in the areas of practice management, clinical
quality initiatives, research and education, yet maintain clinical
autonomy so we can do what we do best – take care of our patients.”
MEDNAX’s American Anesthesiology division consists of more than 1,950
anesthesia providers, including more than 825 physicians and 1,125
anesthetists practicing in Florida, Georgia, Maryland, Michigan, New
Jersey, New York, North Carolina, Tennessee, Texas, and Virginia.
This was a cash transaction, and it is expected to be immediately
accretive to earnings. No additional terms of the transaction were
disclosed.
ABOUT MEDNAX
MEDNAX, Inc. is a national medical group comprised of the nation's
leading providers of neonatal, anesthesia, maternal-fetal and pediatric
physician subspecialty services. Physicians and advanced practitioners
practicing as part of MEDNAX are reshaping the delivery of care within
their specialties and subspecialties, using evidence-based tools,
continuous quality initiatives and clinical research to enhance patient
outcomes and provide high-quality, cost-effective care. Pediatrix
Medical Group, a unit of MEDNAX, was founded in 1979 and now includes
neonatal physicians who provide services at more than 360 neonatal
intensive care units, who collaborate with affiliated maternal-fetal
medicine, pediatric cardiology and pediatric critical care physician
subspecialists to provide a clinical care continuum. Pediatrix is also
the nation's largest provider of newborn hearing screens. In 2007,
MEDNAX expanded into anesthesia services. Today, American Anesthesiology
includes more than 1,950 anesthesiologists and advanced practitioners
who provide anesthesia care to patients in connection with surgical and
other procedures as well as pain management. MEDNAX, through its
affiliated professional corporations, employs more than 2,350 physicians
in 34 states and Puerto Rico. Additional information is available at www.mednax.com.
Certain statements and information in this press release may be
deemed to contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. Forward-looking statements may
include, but are not limited to, statements relating to our objectives,
plans and strategies, and all statements, other than statements of
historical facts, that address activities, events or developments that
we intend, expect, project, believe or anticipate will or may occur in
the future. These statements are often characterized by terminology such
as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”,
“will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and
similar expressions, and are based on assumptions and assessments made
by MEDNAX’s management in light of their experience and their perception
of historical trends, current conditions, expected future developments
and other factors they believe to be appropriate. Any forward-looking
statements in this press release are made as of the date hereof, and
MEDNAX undertakes no duty to update or revise any such statements,
whether as a result of new information, future events or otherwise.
Forward-looking statements are not guarantees of future performance and
are subject to risks and uncertainties. Important factors that could cause
actual results, developments, and business decisions to differ
materially from forward-looking statements are described in MEDNAX’s
most recent Annual Report on Form 10-K and its Quarterly Reports on Form
10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s
current reports on Form 8-K, filed with the Securities and
Exchange Commission.
Source: MEDNAX, Inc.
MEDNAX, Inc.
Charles Lynch, 954-384-0175, x 5692
Vice
President, Strategy and Investor Relations
charles_lynch@mednax.com